Comorbidities and medications of patients with chronic hepatitis C under specialist care in the UK

Designing services with the capacity and expertise to meet the needs of the chronic hepatitis C (CHC) population in the era of direct acting antivirals (DAAs), and widening access to such treatments, requires detailed understanding of the characteristics and healthcare needs of the existing patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Hudson, Benjamin, Walker, Alex J., Irving, William L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656818/
https://www.ncbi.nlm.nih.gov/pubmed/28480974
http://dx.doi.org/10.1002/jmv.24848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656818/
https://www.ncbi.nlm.nih.gov/pubmed/28480974
http://dx.doi.org/10.1002/jmv.24848

Ejemplares similares